TherapeuticsMD, Inc. — Director's Dealing 2014

May 9, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2014-05-08

Reporting Person: Thompson Tommy G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-05-08	Common Stock	P	14000	$3.5742	Acquired	644000	Indirect

Footnotes

F1: The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.555 to $3.5899, inclusive. The reporting person undertakes to provide to TherapeuticsMD., Inc. (the "Company") any security holder of the Companty or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.